Clinical Trials | NIPH Clinical Trials Search

Number of results: 216

Recruiting
Multi-center observational study and present status survey for the establishment of the standard method for the long-term use of HAL.
The subjects will consist of patients with reduced walking function due to slowly progressive neurological/muscular diseases. HAL for medical use (lower limb type) is indicated for the following slowly progressive neurological/muscular diseases:spinal muscular atrophy (SMA), spinal and bulbar muscular atrophy (SBMA), amyotrophic lateral sclerosis (ALS), Charcot-Marie-Tooth disease (CMT), distal myopathy, inclusion body myositis (IBM), congenital myopathy, and muscular dystrophy. Patients who were diagnosed with one of the 8 diseases and require walking assistance or aids will be included as subjects. In addition, even patients who were not definitively diagnosed with one of the above 8 diseases but use HAL in daily medical practice at the attending physician's discretion will be included as subjects.
Takashi Nakajima
2019-08-02

Clinical TrialsSearch results